Health-related quality of life and its risk factors in Chinese hereditary angioedema patients

[1]  P. Keith,et al.  Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. , 2018, The journal of allergy and clinical immunology. In practice.

[2]  A. Maetzel,et al.  Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies , 2018, Orphanet Journal of Rare Diseases.

[3]  R. Lockey,et al.  The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update , 2018, Allergy.

[4]  C. Wahlgren,et al.  Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden. , 2017, Allergy and asthma proceedings.

[5]  N. Prior,et al.  Burden of Illness and Quality-of-Life Measures in Angioedema Conditions. , 2017, Immunology and allergy clinics of North America.

[6]  D. Supina,et al.  Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase. , 2017, Allergy and asthma proceedings.

[7]  Elaine Harniman,et al.  Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36 , 2017, Allergy, Asthma & Clinical Immunology.

[8]  W. Aberer,et al.  Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  P. Martus,et al.  The Angioedema Quality of Life Questionnaire (AE‐QoL) – assessment of sensitivity to change and minimal clinically important difference , 2016, Allergy. European Journal of Allergy and Clinical Immunology.

[10]  Juan José Yepes-Nuñez,et al.  Angioedema hereditario en Medellín, Colombia: evaluación clínica y de la calidad de vida , 2015 .

[11]  M. Maurer,et al.  Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies , 2015, Health and Quality of Life Outcomes.

[12]  K. Andersen,et al.  Health-related quality of life in Danish patients with hereditary angioedema. , 2015, Acta dermato-venereologica.

[13]  J. Yepes-Nuñez,et al.  [Hereditary angioedema in Medellín (Colombia): Clinical evaluation and quality of life appraisal]. , 2015, Biomedica : revista del Instituto Nacional de Salud.

[14]  P. Keith,et al.  Canadian hereditary angioedema guideline , 2014, Allergy, Asthma & Clinical Immunology.

[15]  Hong-Yu Zhang,et al.  Upper airway edema in 43 patients with hereditary angioedema. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[16]  B. Zuraw,et al.  Current update on cellular and molecular mechanisms of hereditary angioedema. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[17]  A. Sheffer,et al.  Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency , 2014, BMC Gastroenterology.

[18]  Erika F. H. Saunders,et al.  Depression and anxiety in patients with hereditary angioedema. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[19]  L. Mallbris,et al.  Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden. , 2014, Allergy and asthma proceedings.

[20]  P. Williams,et al.  A UK national audit of hereditary and acquired angioedema , 2014, Clinical and experimental immunology.

[21]  K. Beusterien,et al.  The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe. , 2014, Allergy and asthma proceedings.

[22]  A. Gompel,et al.  Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  Hong-Yu Zhang,et al.  Clinical features of hereditary angioedema in Chinese patients: new findings and differences from other populations. , 2013, European journal of dermatology : EJD.

[24]  R. Campos,et al.  Hereditary angioedema: quality of life in Brazilian patients , 2013, Clinics.

[25]  Xiu-qiang Ma,et al.  Health-related quality of life in Chinese people: A population-based survey of five cities in China , 2011, Scandinavian journal of public health.

[26]  C. Fagerberg,et al.  Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency , 2011, Allergy.

[27]  W. Lumry,et al.  The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. , 2010, Allergy and asthma proceedings.

[28]  K. Andersen,et al.  Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. , 2009, European journal of dermatology : EJD.

[29]  K. Bork,et al.  Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[31]  M. Greaves,et al.  The extent and nature of disability in different urticarial conditions , 1999, The British journal of dermatology.